Dr. Franklin Huang is a medical oncologist who cares for patients with prostate cancer.

Huang's lab examines genetic differences between cancer cells and normal tissue, aiming to determine what makes certain tumors more aggressive. His work seeks to understand prostate cancer in African Americans and to develop better treatments. His other areas of study include finding new drug targets for cancer patients with precision medicine (an approach that individualizes treatment by considering factors such as genetics and environment) and global oncology (a field focused on expanding access to cancer prevention and treatment). His research receives support from the National Institutes of Health, the United States Department of Defense, the Prostate Cancer Foundation and the Benioff Initiative for Prostate Cancer Research.

Huang earned his doctorate in genetics from Harvard Medical School and his medical degree from Washington University School of Medicine in St. Louis. He completed a residency in internal medicine at Massachusetts General Hospital and a fellowship in hematology and oncology at Dana-Farber Cancer Institute; both hospitals are Harvard affiliates. He is a co-founder of Global Oncology, a nonprofit working to improve cancer care for underserved patients around the world.

Dr. Cecchini and colleagues were the first laboratory to describe the three dimensional structure of Complex II (succinate dehydrogenase), a key member of the energy generating component of the mitochondrion, the "power plant" of the cell. Their findings show how the architecture of this family of enzymes is arranged to lessen the formation of reactive oxygen species (ROS), which are thought to be important for diseases such as aging, cancer, neurodegeneration, and heart disease.

Dr. Jarvis's research program is focused on investigating questions of innate immunity in three experimental systems: (1) studying innate immune responses to gonococcal and chlamydial infection, (2) examining questions of the structure and function of endotoxin, and (3) looking at endotoxin as a potential therapeutic for acute traumatic brain injury.

Dr. Hsu is the Hematology/Oncology Fellowship Program Director in the at UCSF. He grew up in Edmonton, Canada and the San Francisco Bay Area. After completing his medical and graduate degree in Biochemistry at Duke University and residency at Brigham & Women’s Hospital, Dr. Hsu made his way back to the Bay Area for fellowship in medical oncology at UCSF. Dr. Hsu practices at the San Francisco VA Medical Center with a particular interest in hematologic malignancies. He has been involved with curriculum development and educational initiatives at the medical school and post-graduate level at UCSF and is a member of the UCSF Haile T. Debas Academy of Medical Educators.

Dr. Ghuman�s research focuses on repairing neural circuits after injury by integrating biological (stem cell transplantation and biomaterials) and artificial (electrical and optical) interfaces to promote circuit integration and functional recovery.